Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I-II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study.

Saved in:
Bibliographic Details
Title: Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I-II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study.
Authors: Podlipnik S; Department of Dermatology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain., Boada A; Department of Dermatology, Hospital Universitari Germans Trias i Pujol, Institut d'investigació Germans Trias Badalona, 08916 Barcelona, Spain., López-Estebaranz JL; Department of Dermatology, Hospital Universitario Fundación Alcorcón, Alcorcón, 28922 Madrid, Spain., Martín-González MM; Department of Dermatology, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain., Redondo P; Department of Dermatology, University Clinic of Navarra, 31008 Pamplona, Spain., Martin B; Castle Biosciences, Inc., Friendswood, TX 77546, USA., Quick AP; Castle Biosciences, Inc., Friendswood, TX 77546, USA., Bailey CN; Castle Biosciences, Inc., Friendswood, TX 77546, USA., Kurley SJ; Castle Biosciences, Inc., Friendswood, TX 77546, USA., Cook RW; Castle Biosciences, Inc., Friendswood, TX 77546, USA., Puig S; Department of Dermatology, Hospital Clinic of Barcelona, 08036 Barcelona, Spain.; Department of Dermatology, University of Barcelona, IDIBAPS, 08007 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, CIBERER, Instituto de Salud Carlos III, 46010 Barcelona, Spain.
Source: Cancers [Cancers (Basel)] 2022 Feb 19; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 19.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2072-6694
DOI:10.3390/cancers14041060